Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand - Bielekova,B.; Goodwin,B.; Richert,N. (Nat Med, 2000)